Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
70.34
+1.23 (1.79%)
Sep 1, 2026, 10:50 AM EDT - Market open
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $230.28 million as of September 1, 2026. Its market cap has increased by 262.64% in one year.
Market Cap
230.28M
Enterprise Value
183.12M
1-Year Change
262.64%
Ranking
Category
Stock Price
$70.34
ChartMarket Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has increased from $228.30M to $230.28M, an increase of 0.87%. That is a compound annual growth rate of 0.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 230.28M | 96.15% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 233.32M |
| Tonix Pharmaceuticals Holding | 233.08M |
| Minerva Neurosciences | 231.10M |
| Greenwich LifeSciences | 230.01M |
| Protara Therapeutics | 225.74M |
| Keros Therapeutics | 218.69M |
| Voyager Therapeutics | 218.13M |
| Coherus Oncology | 217.85M |